Association of genetic variants in the promoter region of genes encoding p22phox (CYBA) and glutamate cysteine ligase catalytic subunit (GCLC) and renal disease in patients with type 1 diabetes mellitus

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Vieira, Suzana M ^a,b   Monteiro, Maria B ^a   Marques, Tatiana ^a   Luna, Ana M ^a   Fortes, Maria A ^a   Nery, Márcia ^a   Queiroz, Márcia ^a   Dib, Sérgio A ^c   Vendramini, Márcio F ^b   Azevedo, Mirela J ^d   Canani, Luis H ^d   Parisi, Maria C ^e   Pavin, Elizabeth J ^e   Giannella Neto, Daniel ^a   Corrêa Giannella, Maria L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; CYBA PROTEIN, HUMAN; GLUTATHIONE PEROXIDASE; GPX3 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE PREDISPOSITION; FEMALE; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; GLUTATHIONE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION REACTION; PROMOTER REGION; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; ENZYME ACTIVE SITE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

ANIMALIA;

ADULT; CASE-CONTROL STUDIES; CATALYTIC DOMAIN; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 80053356169     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-129     Document Type: Article

References (21)

1. Klein R, Klein B, Moss S, Davis M, DeMets D. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984, 102:520-526.
2. Gross J, de Azevedo M, Silveiro S, Canani L, Caramori M, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28:164-176. 10.2337/diacare.28.1.164, 15616252.
3. Seaquist E, Goetz F, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989, 320:1161-1165. 10.1056/NEJM198905043201801, 2710189.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820. 10.1038/414813a, 11742414.
5. Gill PS, Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 2006, 8:1597-1607. 10.1089/ars.2006.8.1597, 16987014.
6. Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, Nawata H. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabetologia 2003, 46:1428-1437. 10.1007/s00125-003-1205-6, 13680125.
7. Samiec P, Drews-Botsch C, Flagg E, Kurtz J, Sternberg PJ, Reed R, Jones D. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 1998, 24:699-704. 10.1016/S0891-5849(97)00286-4, 9586798.
8. Koide S, Kugiyama K, Sugiyama S, Nakamura S, Fukushima H, Honda O, Yoshimura M, Ogawa H. Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction. J Am Coll Cardiol 2003, 41:539-545.
9. Voetsch B, Jin R, Bierl C, Benke K, Kenet G, Simioni P, Ottaviano F, Damasceno B, Annichino-Bizacchi J, Handy D, Loscalzo J. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 2007, 38:41-49. 1781064, 17122425.
10. Moreno M, San José G, Fortuño A, Beloqui O, Redón J, Chaves F, Corella D, Díez J, Zalba G. A novel CYBA variant, the -675A/T polymorphism, is associated with essential hypertension. J Hypertens 2007, 25:1620-1626. 10.1097/HJH.0b013e3281ac211d, 17620958.
11. Kramer C, Leitão C, Azevedo M, Valiatti F, Rodrigues T, Canani L, Gross J. Diabetic retinopathy is associated with early autonomic dysfunction assessed by exercise-related heart rate changes. Braz J Med Biol Res 2008, 41:1110-1115. 10.1590/S0100-879X2008001200011, 19148374.
12. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006, 38:209-213. 10.1038/ng1706, 16415888.
13. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: a Practical and Powerful. Approach to Multiple Testing. Journal of the Royal Statistical Society 1995, 57(1):289-300.
14. Satoh M, Fujimoto S, Haruna Y, Arakawa S, Horike H, Komai N, Sasaki T, Tsujioka K, Makino H, Kashihara N. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol 2005, 288:F1144-1152. 10.1152/ajprenal.00221.2004, 15687247.
15. Hodgkinson AD, Millward BA, Demaine AG. Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. Diabetes Care 2003, 26:3111-3115. 10.2337/diacare.26.11.3111, 14578247.
16. Isoe T, Makino Y, Mizumoto K, Sakagami H, Fujita Y, Honjo J, Takiyama Y, Itoh H, Haneda M. High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein. Kidney Int 2010, 78:48-59. 10.1038/ki.2010.99, 20375990.
17. Campolo J, Penco S, Bianchi E, Colombo L, Parolini M, Caruso R, Sedda V, Patrosso MC, Cighetti G, Marocchi A, Parodi O. Glutamate-cysteine ligase polymorphism, hypertension, and male sex are associated with cardiovascular events. Biochemical and genetic characterization of Italian subpopulation. Am Heart J 2007, 154:1123-1129. 10.1016/j.ahj.2007.07.029, 18035085.
18. Oliveira CP, Stefano JT, Cavaleiro AM, Zanella Fortes MA, Vieira SM, Rodrigues Lima VM, Santos TE, Santos VN, de Azevedo Salgado AL, Parise ER, Ferreira Alves VA, Carrilho FJ, Corrêa-Giannella ML. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2010, 25:357-361. 10.1111/j.1440-1746.2009.06001.x, 19817962.
19. Bekris LM, Shephard C, Janer M, Graham J, McNeney B, Shin J, Zarghami M, Griffith W, Farin F, Kavanagh TJ, Lernmark A. Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels. Exp Clin Endocrinol Diabetes 2007, 115:221-228. 10.1055/s-2007-970574, 17479437.
20. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci USA 2003, 100:177-182. 10.1073/pnas.0126614100, 140919, 12509516.
21. Gamble DR. The epidemiology of insulin dependent diabetes with particular reference to the relationship of virus infection to its etiology. Epidemiol Rev 1980, 2:49-70.